Upgrading emergency dispatch

Israel’s volunteer emergency medical organization United Hatzalah has just enhanced its dispatch center’s capabilities by upgrading to the APEX cloud-based system from Israel’s Carbyne (see previously). United Hatzalah partnered with Carbyne (see ) after the Turkish earthquake.

Looking to stop cancer at cell level

Dr Gabriel Frank at Israel’s Ben Gurion University employs microscopy – examining cells using BGU’s powerful cryo-electron microscope, He has discovered that cancer cells rely on iron ions. The body’s Nuclear Receptor Coactivator 4 (NCOA4) controls the ion level and can kill the cancer.

Papaya to treat cystic fibrosis

Israel’s ODE Pharma has discovered that a molecule, code named ODE-001 and derived from the papaya fruit, reduces inflammation and deterioration in organs adversely affected by cystic fibrosis. One scientist who originally suggested the molecule is Nobel laureate Aaron Ciechanover.

Big data is revealing

A 2-year study by Tel Aviv University researchers is being hailed as a test for vaccines and also to give early warning of a potential pandemic. Smartwatch sensors from Israel’s Biobeat (see previously) monitored the heart, lungs, blood oxygen, temperature, blood pressure, etc. of some 5,000 patients.

Hope for colorectal cancer patients

Early results of a study at Israel’s Rabin Medical Center of 29 patients showed new treatment for colorectal cancer eradicated tumors in 65% of patients and prevented surgery for most. Combined immunotherapy and chemoradiotherapy substantially improved survival and quality of life.

Robot can help rehabilitate stroke patients

Ben Gurion University researchers published the first long-term study of stroke patient rehabilitation using Socially Assistive Robots (SARs).  The robots used speech, facial expressions, and gestures to guide and coach patients and improve outcomes.  (See also previously).

Almost no re-ocurrence after freezing tumors

Israel’s IceCure Medical (see previously) presented the results of its three clinical studies using ProSense to treat breast cancer. Of the 389 patients treated, The ipsilateral tumor recurrence rate was 0.26%, resulting in a 99.74% recurrence-free rate.

Breakthrough device treats heart failure

Israel’s Restore Medical (see previously) has been granted Breakthrough Device Designation by the U.S. FDA for its transcatheter Pulmonary Artery Banding (PAB) system designed for patients suffering from left ventricle failure who currently have limited treatment options.

Still smiling

If you wanted to know what happened to Aerodentis (see previously) from Israel’s Dror Ortho-Design, there is good news. Aerodentis has been rebranded as Zsmile and its orthodontic system that straightens your teeth while you sleep is about to launch commercially.

High-school space experiment

4 years ago, six Israeli 9th-grade students put an experiment about brain disease progression aboard the International Space Station. The results have just been published in the June edition of Astrobiology. If repeated, it could have major implications for neurodegenerative disease treatment.